Refreshed content for Thymosin Alpha-1ai_activityai-researcherApr 17, 2026
Pulled 4 linked studies for context.
No external link
Summary not yet generated. The Librarian will pick this up on the next daily run (12:00 UTC).
Community effect votes, structured logs, and side-effect summaries.
Effect profile (overview)
Aggregate AI baseline blended with community voting. Hover to inspect effect strengths per category.
Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.
Research log summary heatmap
Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.
No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.
Anonymous side-effect patterns
Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.
No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.
Research footprint
Last analyzed Apr 17, 20265
Studies indexed
0
Human
0
Animal
1
AI analyzed
Evidence mix0% human · 0% animal · 0% cellular · 0% review
Highest phase: Preclinical onlyYears covered: 2025
Librarian pulse — latest actionsFull changelog ↓
- Apr 17, 12:04 PMRefreshedRefreshed content for Thymosin Alpha-1
- Apr 16, 5:14 PMRefreshedRefreshed content for Thymosin Alpha-1
- Apr 16, 5:14 PMRefreshedRefreshed content for Thymosin Alpha-1
Research & intelligence feed
Studies, clinical trials, community discussions, and news.
Refreshed content for Thymosin Alpha-1ai_activityai-researcherApr 16, 2026
Pulled 4 linked studies for context. - **content** added: Body content generated (1430 chars).
No external link
Refreshed content for Thymosin Alpha-1ai_activityai-researcherApr 16, 2026
Pulled 4 linked studies for context. - **content** added: Body content generated (1065 chars).
No external link
Investigator Initiated Study of Thymosin in HBV-related HCCClinical TrialClinicalTrials.govApr 16, 2026
This study investigated the effects of Thymosin Alpha-1 in patients with HBV-related hepatocellular carcinoma (HCC). The specific outcomes measured and the dosing regimen were not detailed in the abstract. The study's findings are not clearly reported.
Phase: PHASE4Status: UNKNOWN
A Prospective Multi-center Phase II Study: Assessment of the Safety and Abscopal Effects of SBRT Combination With rhGM-CSF and Thymosin Alpha 1 for Stage IV NSCLC Patients Who Failed in Second-line ChemotherapyClinical TrialClinicalTrials.govApr 16, 2026
This study assessed the safety and abscopal effects of SBRT combined with rhGM-CSF and Thymosin Alpha-1 in stage IV NSCLC patients who failed second-line chemotherapy. The specific doses and outcomes are not detailed in the abstract. The study is significant as it explores potential new treatment combinations for a challenging patient population.
Phase: PHASE2Status: UNKNOWN
Combination Treatment of Polyethylene Glycol Thymosin alpha1 (PEG-Tα1) and Adefovir for Hepatitis B e Antigen (HBeAg) -Positive Chronic Hepatitis B: A Multi-center Randomized, Double-blind, Parallel-controlled Phase II TrialClinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the efficacy of a combination treatment of Polyethylene Glycol Thymosin alpha1 (PEG-Tα1) and Adefovir in patients with HBeAg-positive chronic hepatitis B. The trial was a multi-center, randomized, double-blind, parallel-controlled Phase II study. Not reported in abstract.
Phase: PHASE2Status: COMPLETED
A Phase II Trial of Hypofractionated Radiotherapy Combined With Thymosin for Metastatic NSCLC Patients Who Showed Stable Disease After First Line TKI TherapyClinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the effects of hypofractionated radiotherapy combined with Thymosin Alpha-1 in patients with metastatic non-small cell lung cancer (NSCLC) who had stable disease after first-line TKI therapy. The specific outcomes measured were not detailed in the abstract. The study was conducted as a Phase II trial.
Phase: PHASE2Status: UNKNOWN
Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)Clinical TrialClinicalTrials.govApr 16, 2026
This study evaluated the protective effects of Ulinastatin and Thymosin α1 against immune dysregulation and organ dysfunction following acute aortic dissection surgery. The specific doses and outcomes measured were not reported in the abstract. The study is registered on ClinicalTrials.gov.
Phase: NAStatus: ENROLLING_BY_INVITATION
Semantic Scholar search for Thymosin Alpha-1StudySemanticScholarDec 12, 2025
Efficacy of thymosin α1 for sepsis: a systematic review and meta-analysis of randomized controlled trials.StudyPubMedDec 12, 2025
Frontiers in cellular and infection microbiology · 2025
Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.StudyPubMedDec 12, 2025
British journal of hospital medicine (London, England : 2005) · 2025
Thymosin α1 alleviates pulpitis by inhibiting ferroptosis of dental pulp cells.StudyPubMedDec 12, 2025
International journal of oral science · 2025
External databases
Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.
Community notes
No comments yet. Share research notes, citations, or observations below.
Community research logs (detail)
No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.
Anonymous side-effect reporting (detail)
This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.
Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.
Librarian Changelog
Every time the Librarian touches this peptide — discovering, refreshing, scoring, or verifying — it logs the action here.
20h agoRefreshai-researcher85%
Refreshed content for Thymosin Alpha-1
1d agoRefreshai-researcher85%
Refreshed content for Thymosin Alpha-1
1d agoRefreshai-researcher85%
Refreshed content for Thymosin Alpha-1